GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » EV-to-EBITDA

Huadong Medicine Co (SZSE:000963) EV-to-EBITDA : 15.20 (As of May. 05, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Huadong Medicine Co's enterprise value is ¥56,120 Mil. Huadong Medicine Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3,692 Mil. Therefore, Huadong Medicine Co's EV-to-EBITDA for today is 15.20.

The historical rank and industry rank for Huadong Medicine Co's EV-to-EBITDA or its related term are showing as below:

SZSE:000963' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.06   Med: 20.16   Max: 29.49
Current: 15.2

During the past 13 years, the highest EV-to-EBITDA of Huadong Medicine Co was 29.49. The lowest was 8.06. And the median was 20.16.

SZSE:000963's EV-to-EBITDA is ranked worse than
51.63% of 705 companies
in the Drug Manufacturers industry
Industry Median: 14.53 vs SZSE:000963: 15.20

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-05), Huadong Medicine Co's stock price is ¥32.94. Huadong Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.682. Therefore, Huadong Medicine Co's PE Ratio for today is 19.58.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Huadong Medicine Co EV-to-EBITDA Historical Data

The historical data trend for Huadong Medicine Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co EV-to-EBITDA Chart

Huadong Medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.68 11.55 19.58 20.95 16.02

Huadong Medicine Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.03 22.49 20.74 16.02 14.42

Competitive Comparison of Huadong Medicine Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Huadong Medicine Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huadong Medicine Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huadong Medicine Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Huadong Medicine Co's EV-to-EBITDA falls into.



Huadong Medicine Co EV-to-EBITDA Calculation

Huadong Medicine Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=56119.885/3691.694
=15.20

Huadong Medicine Co's current Enterprise Value is ¥56,120 Mil.
Huadong Medicine Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,692 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huadong Medicine Co  (SZSE:000963) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Huadong Medicine Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=32.94/1.682
=19.58

Huadong Medicine Co's share price for today is ¥32.94.
Huadong Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.682.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Huadong Medicine Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Huadong Medicine Co (SZSE:000963) Business Description

Traded in Other Exchanges
N/A
Address
468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006
Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines